Letter to the Editor

HAc40 is a novel microbiome modulator, effective on atopic dermatitis in children: data from two pilot vehicle-controlled trials

R. Sacchetti, G. Gregori, E. Moggio, L. Gobbo, L. Bonzano, G Pellacani

First published: 01 June 2021 https://doi.org/10.1111/jdv.17431

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/jdv.17431
Abstract

Microbial balance is fundamental to healthy skin and changes in this ecosystem may lead to several diseases.1 Atopic dermatitis (AD) is associated with altered skin microbiome, prevalence of Saureus colonization and secondary infections.2,3 Due to prevalence of microbial resistance, antibiotics usage for treating AD has been discouraged4 and several attempts have been conducted to restore a microbiome balance through skin bacteria replacement.5

R. Sacchetti, G. Gregori, E. Moggio, L. Gobbo, L. Bonzano, G Pellacani

First published: 01 June 2021 https://doi.org/10.1111/jdv.17431

This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/jdv.17431
Abstract

Microbial balance is fundamental to healthy skin and changes in this ecosystem may lead to several diseases.1 Atopic dermatitis (AD) is associated with altered skin microbiome, prevalence of Saureus colonization and secondary infections.2,3 Due to prevalence of microbial resistance, antibiotics usage for treating AD has been discouraged4 and several attempts have been conducted to restore a microbiome balance through skin bacteria replacement.5